adcock, i.m., brown, c.r., kwon, o. and barnes, p.j...
TRANSCRIPT
References
119
Adcock, I.M., Brown, C.R., Kwon, O. and Barnes, P.J., Oxidative stress induces NF
kappa B DNA binding and inducible NOS mRNA in human epithelial cells.
Biochem. Biophys. Res. Commun., 1994, 199, 1518-1524.
Advanced Chemistry Development / ChemSketch software, http://www.acdlabs.com/
download/sda.
Aggarwal, B.B., Nuclear factor-kappaB: the enemy within. Cancer Cell., 2004, 6(3), 203-
208.
Aggarwal, B.B., Shishir, S., Santosh, K.S., Manoj, K.P. and Gautam, S., Inflammation
and cancer: how hot is the link?. Biochem. Pharmacol., 2006, 72, 1605-21.
Aggarwal, B.B., Vijayalekshmi, R.V. and Bokyung, S., Targeting Inflammatory
Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term
Foe. Clin. Cancer. Res., 2009, 15, 425-430.
Akao, Y., Nakagawa, Y., Iinuma, M. and Nozawa, Y., Anti-Cancer Effects of Xanthones
from Pericarps of Mangosteen. Int. J. Mol. Sci., 2008, 9, 355-370.
Akira, M. and Hajime, O., Targeting NOX, INOS and COX-2 in inflammatory cells:
chemoprevention using food phytochemicals. Int. J. Cancer., 2007, 121(11),
2357-2363.
Ahmat, N., Nik, F.N.A., Nurunajab, A.G., Sharipah, R.S.A., Norrizah, J.S., Shamsiah, A.
and Halila, J., Bioactive Xanthones from the pericarp of Garcinia mangostana.
Mid-East. J. Sci. Res., 2010, 6(2), 123-127.
AutoDock software, http://www.scripps.edu/pub/olson-web/doc/autodock/
References
120
Ayumi, S., Hironori, F., Hisae, O., Kyoko, I. and Yasushi, O., α-Mangostin Induces Ca2+
-
ATPase-Dependent Apoptosis via Mitochondrial Pathway in PC12 Cells. J.
Pharmacol. Sci., 2004, 95, 33-40.
Baeuerle, P.A. and Baltimore, D., Nf-κB: ten years after. Cell., 1996, 87(1), 13-20.
Bakhle, Y.S., Structure of COX-1 and COX-2 enzymes and their interaction with
inhibitors. Drugs Today., 1999, 35, 237-250.
Balunas, M.J. and Kinghorn, A.D., Drug discovery from medicinal plants. Life Sci., 2005,
78,431-441.
Barnes, P.J., Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin.
Sci., 1998, 94, 557-572.
Baskar, R., Rajeswari, V. and Satish, K.T., In vitro antioxidant studies in the leaves of
Annona species. Ind. J. Exp. Biol., 2007, 45, 480-485.
Blois, M.S., Antioxidant determination by the use of stable free radicals. Nature., 1958,
26, 1199-1200.
Brash, A.R., Arachidonic acid as a bioactive molecule. J. Clin. Invest., 2001, 107,1339-
1345.
Braugghler, J.M., Duncan, C.A. and Chase, L.R., The involvement of iron in lipid
peroxidation, Important of ferrous to ferric iron in initiation, J. Biol. Chem., 1986,
261, 10282.
Bobbili, V.V.P., Mubarak, A.A., Leela, K.A., Reddanna, P. and Ashok, K.,
Phycocyanin-mediated apoptosis in AK-5 tumor cells involves down-
References
121
regulation of Bcl-2 and generation of ROS. Mol. Cancer. Ther., 2003, 2, 1165-
1170.
Bonventre, J.V., Huang, Z., Taheri, M.R., O’Leary, E., Li, E., Moskowitz, M.A. and
Sapirstein, A., Reduced fertility and postischaemic brain injury in mice deficient
in cytosolic phospholipase A2. Nature., 1997, 390, 622-625.
Borenfreund, E., Babich, H. and Martin, A.N., Comparisons of two in vitro cytotoxicty
assays-the neutral red (NR) and tetrazolium MTT tests. Toxicol. In vitro., 1988, 2,
1-6.
Bumrungpert, A., Ruchaneekorn, W.K., Chia-Chi, C., Angel, O., Kristina, M., Arion, K.
and Michael, M., Xanthones from mangosteen inhibit inflammation in human
macrophages and in human adipocytes exposed to macrophage-conditioned
media. J. Nutr., 2010, 140, 842-847.
Callan, O.H., So, O.Y. and Swinney, D.C., The kinetic factors that determine the affinity
and selectivity for slow binding inhibition of human prostaglandin H synthase 1
and 2 by indomethacin and flurbiprofen. J. Biol .Chem., 1996, 271(7), 3548-3554.
Carla, M.P., Milton, A.M., Iolanda, F.L. and Tiberio, C., Nitric Oxide in Asthma
Physiopathology. ISRN Allergy., 2011,1-13.
Cedergren, J., Forslund, T., Sundqvist, T. and Skogh, T., Inducible nitric oxide synthase
is expressed in synovial fluid granulocytes. Clin. Exp. Immunol., 2002, 130, 150-
155.
Chairungsrilerd, N., Furukawa, K., Ohta, T., Nozoe, S. and Ohizumi, Y.,
Pharmacological properties of α-mangostin, a novel histamine H1 receptor
antagonist. Eur. J. Pharmacol., 1996, 314, 351-356.
References
122
Chandrasekharan, N.V. and Simmons, D.L., The cyclooxgenases. Genome Biol., 2004, 5,
241.
Charles, I.G., Palmer, R.M., Hickery, M.S., Bayliss, M.T., Chubb, A.P., Hall, V.S., Moss,
D.W. and Moncada, S., Cloning, characterization and expression of a cDNA
encoding an inducible nitric oxide synthase from the human chondrocyte. Proc.
Nat. Aca. Sci. USA., 1993, 90, 11419-11423.
Charles, N.S, Chiang, N. and Dyke, V.T.E., Resolving inflammation: dual anti-
inflammatory and pro-resolution lipid mediators. Nature Rev. Immunol., 2008, 8,
49-361.
Crane, B.R., Arvai, A.S., Ghosh, D.K., Wu, C., Getzoff, E.D., Stuehr, D.J. and Tainer,
J.A., Structure of nitric oxide oxygenase dimer with pterin and substrate. Science.,
1998, 279, 2121-2126.
Chao, W.W., Hong, Y.H., Chen, M.L. and Lin, B.F., Inhibitory effects of Angelica
sinensis ethyl acetate extract and major compounds on NF-κB trans-activation
activity and LPS-induced inflammation. J. Ethnopharmacol., 2010, 29(2), 244-
249.
Chang, J., Medicinal herbs: drugs or dietary supplements?. Biochem. Pharmacol., 2000,
59, 211-219.
Chen, S.X., Wan, M. and Loh, B.N., Active constituents against HIV-1 protease from
Garcinia mangostana. Planta Med., 1996, 62, 381-382.
Chen, M.J, Chiou, P.P, Lin, P., Lin, C.M., Siri, S., Peck, K. and Chen, T.T., Suppression
of growth and cancer-induced angiogenesis of aggressive human breast cancer
cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken
embryos by E-peptide of pro-IGF-I. J. Cell Biochem., 2007, 101(5), 1316-27.
References
123
Chen, L.G., Yang, L.L. and Wang, C.C., Anti-inflammatory activity of mangostins from
Garcinia mangostana. Food. Chem. Toxicol., 2008, 46, 688-694.
Chin, Y.W., Jung, H.A., Chai, H., Keller, W.J. and Kinghorn, A.D., Xanthones with
quinone reductase-inducing activity from the fruits of Garcinia mangostana
(Mangosteen). Phytochem., 2008, 69, 754-758.
Cho, H., Yun, C.W., Park, W.K., Kong, J.Y., Kim, K.S., Park, Y., Lee, S. and Kim, B.K.,
Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by
chrysin derivatives. Pharmacol. Res., 2004, 49(1), 37-43.
Cianchi, F., Cortesini, C., Fantappie, O., Messerini, L., Schiavone, N., Vannacci, A.,
Nistri, S., Sardi, I., Baroni, G., Marzocca, C., Perna, F., Mazzanti, R., Bechi, P.
and Masini, E., Inducible nitric oxide synthase expression in human colorectal
cancer: correlation with tumor angiogenesis. Ame. J. Pathol., 2003, 162, 793-
801.
Clive, D.M. and Stoff, J.S., Renal syndromes associated with non-steroidal anti-
inflammatory drugs. New Eng. J. Med., 1984, 310, 563-572.
Colin, B. and Carlo, P., Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular
disease: A reappraisal. Arth. Rheum., 2003, 48 (1), 12-20.
Coussens, L.M. and Werb, Z., Inflammation and cancer. Nature., 2002, 420 (6917), 860-
867.
Cross, R.K. and Wilson, KT., Nitric oxide in inflammatory bowel disease. Inflam. Bowel
Dis., 2003, 9, 179-89.
Cryer, B., NSAID-associated deaths: The rise and fall of NSAID-associated GI mortality.
Ame. J. Gastroenterol., 2005,100, 1694-1695.
References
124
Dannenberg, A.J, Altorki, N.K, Boyle, J.O., Dang, C., Howe, L.R., Weksler, B.B.
and Subbaramaiah, K., Cyclooxygenase 2: A pharmacological target for the
prevention of cancer. Lancet Oncol., 2001, 2, 544-551.
D'Arcy, P.F., Howard, E.M., Muggleton, P.W. and Townsend, S.B., The anti-
inflammatory action of Griseofulvin in experimental animals. J. Pharm.
Pharmacol., 1960, 12, 659-665.
Danial, N.N. and Korsmeyer, S.J., Cell death: critical control points. Cell., 2004, 23, 205-
219.
Davies, G., Martin, L.A., Sacks, N. and Dowsett, M., Cyclooxygenase -2 (COX-2),
aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer
chemoprevention. Ann. Oncol., 2002, 13, 669-678.
Delas, H. and Hortelano, S., Molecular basis of the anti-inflammatory effects of
terpenoids. Inflam. Allergy Drug Targets., 2009, 8(1), 28-39.
Desiraju, G.R., Gopalakrishnan, B., Jetti, R.K.R., Nagaraju, A., Raveendra, D., Sarma,
J.A.R., Sobhia, P.M.E. and Thilagavathi, R., Computer-Aided Design of
Selective COX-2 Inhibitors: Comparative Molecular Field Analysis, Comparative
Molecular Similarity Indices Analysis, and Docking Studies of Some 1,2-
Diarylimidazole Derivatives. J. Med. Chem. 2002, 45, 4847-4857.
De Luca, F., Impaired growth plate chondrogenesis in children with chronic illnesses.
Pediatric Res., 2006, 59, 625-629.
Devasagayam, T.P.A., Boloor, K.K. and Ramasarma, T., Methods for estimating lipid
peroxidation: An analysis of merits and demerits. Ind. J. Biochem. Biophy., 2003,
40, 300-308.
References
125
Donnelly, L.E. and Barnes, P.J., Expression and regulation of inducible nitric oxide
synthase from human primary airway epithelial cells. Ame. J. Respir. Cell Mol.
Biol., 2002, 26, 144-51.
Dragendorff, O., Uber das Harz von Garcinia mangostana L. Liebigs. Ann., 1930, 482,
280-301.
Ecobichon, D.J., The basis of toxicology testing, CRC Publishing, 1997, 2nd
edn.
Edwina, N. and Vishva, M.D., Mitochondrial reactive oxygen species drive
proinflammatory cytokine production. J. Exp. Med., 2011, 208(3), 417-420.
Elder, D.J., Halton, D.E., Crew, T.E. and Paraskeva, C., Apoptosis induction and
cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell
lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-
398. Int. J. Cancer., 2000, 86(4), 553-60.
Esko, K., On the role of the inducible enzymes iNOS and COX-2 in colitis. Academic
dissertation, University of Helsinki, 2002.
Emanuela, R. and Garret, A.F., Prostaglandins and Inflammation. Arterioscler. Thromb.
Vasc. Biol., 2011, 31, 986-1000.
Evan, G. and Littlewood, T., A Matter of Life and Cell Death. Science., 1998, 281, 1317-
1322.
Fabio, C. and Emanuela, M., Inducible Nitric Oxide Synthase/Cyclooxygenase-2
Pathway Interaction: A Good Molecular Target for Cancer Treatment. Forum.
Immun. Dis. Ther., 2010, 1(3), 183-204.
Fairbairn., The comet assay: a comprehensive review. Mut. Res., 1995, 339, 37-59.
References
126
Ferrero, L.M., Nielsen, O.H., Andersen, P.S. and Girardin, S.E., Chronic inflammation:
importance of NOD2 and NALP3 in interleukin-1β generation. Clin. Exp.
Immunol., 2006,147, 227-235.
Feng, J., Yamakuni, T., Katoh, T., Hosoda, S. and Ohizumi, Y., Potent antioxidant
activity of unripe fruits of Garcinia mangostana L. Natural Med., 2004, 58, 156-
159.
Franchimont, D., Kino, T., Galonm J., Meduri, G.U. and Chrousos, G., Glucocorticoids
and inflammation revisited: The state of the art. Neuroimmunomod., 2003,10,
247-260.
Funk, C.D., Funk, L.B., Kennedy, M.E., Pong, A.S. and Fitzgerald, G.A., Human
platelet/erythroleukemia cell prostaglandin G/H sunthase; cDNA cloning,
expression and gene chromosomal assignment. FASEB J., 1991, 5, 2304-2312.
Gargi, B.D., Pathangey, L.B., Tinder, T.L., LaGioia, M., Gendler, S.J. and Mukherjee. P.,
COX-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of
spontaneous metastatic breast cancer. Mol. Cancer Res., 2004, 2, 632-642.
Ganesh, C.J., Shaival, K.R., Manjeshwar, S.B. and Kiran, S.B., The Evaluation of Nitric
Oxide Scavenging Activity of Certain Herbal Formulations in vitro: A
Preliminary Study. Phytother. Res., 2004, 18, 561-565.
Geert, W.S.S., Analysis of Inflammation. Ann. Rev. Biomed. Eng., 2006, 8, 93-151.
Geller, D.A., Lowenstein, C.J., Shapiro, R.A., Nussler, A.K., Di Silvio, M., Wang, S.C.,
Nakayama, D.K., Simmons, R.L., Snyder, S.H. and Billiar, T.R., Molecular
cloning and expression of inducible nitric oxide synthase from human
hepatocytes. Proc. Nat. Aca. Sci. USA., 1993, 90, 3491-3495.
References
127
Geller, D.A. and Billiar, T.R., Molecular biology of nitric oxide synthases. Cancer
Metastasis Rev., 1998, 17(1), 7-23.
Ghosh, M.N., Fundamentals of Experimental Pharmacology, Hilton & Company
Publishing, 2008, 4th
edn.
GOLD software, http://www.ccdc.cam.ac.uk/prods/gold/
Gopalakrishnan, G., Banumathi, B. and Suresh, G., Evaluation of the antifungal activity
of natural xanthones from Garcinia mangostana and their synthetic derivatives.
J. Nat. Prod., 1997, 60, 519-524.
Goulding, N.J., The molecular complexity of glucocorticoids actions in inflammation a
four-ring circus. Curr. Opinion in Pharmacol., 2004, 4, 629-636.
Griffith, O.W. and Stuehr, D.J., Nitric oxide synthases: properties and catalytic
mechanism. Ann. Rev. Physiol., 1995, 57, 707-736.
Griffin, M.R., Yared, A. and Ray, W.A., Non-steroidal anti-inflammatory drugs and
acute renal failure in elderly persons. Am. J. Epidemiol., 2000, 151, 488-496.
Guha, M. and Mackman, N., Lipopolysaccharide induction of gene expression in human
monocytes. Cell Signalling., 2001, 13, 85-94.
Guillermo, R., Anadel, P. and Jorge, L.Z., Neutral red uptake assay for the estimation of
cell viability/cytotoxicity. Nature Protocols., 2008, 3, 1125-1131.
Gurib, F.A., Medicinal plants: Traditions of yesterday and drugs of tomorrow. Mol.
Aspects Med., 2006, 27(1), 1-93.
References
128
Half, E., Tang, X.M., Gwyn, K., Sahin, A., Wathen, K. and Sinicrope, F.A.,
Cyclooxygenase-2 expression in human breast cancers and adjacent ductal
carcinoma in situ. Cancer Res., 2002, 62(6), 1676-81.
Hall, A.V., Antoniou, H., Wang, Y., Cheung, A.H., Arbus, A.M., Olson, S.L., Lu, W.C.,
Kau, C.L. and Marsden, P.A., Structural organization of the human neuronal nitric
oxide synthase gene (NOS1). J. Biol. Chem., 1994, 269, 33082-33090.
Halliwell, B., Superoxide-dependent formation of hydroxyl free radicals in the presence
of iron chelates. FEBS Lett., 1978, 92, 321.
Halliwell, B., Free radicals, antioxidants, and human disease: curiosity, cause, or
consequence?, Lancet., 1994, 344, 721-724.
Hao, X.P., Pretlow, T.G., Rao, J.S. and Pretlow, T.P., Inducible nitric oxide synthase
(iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal
tumors from the same patients. Cancer Res., 2001, 61, 419-22.
Hemmani, T. and Parihar, M.S., Reactive oxygen species and oxidative damage. Ind. J.
Physiol. Pharmacol., 1998, 42, 440.
Hernandez, P.M. and Rabanal, G.R.M., Evaluation of the anti- inflammatory and
analgesic activity of Sideritis canariensis var pannosa in mice. J.
Ethnopharmacol., 2002, 81, 43-47.
Henry, L.E.A., Halliwell, B. and Hall, D.O., The superoxide dismutase activity of various
photosynthetic organisms measured by a new and rapid assay technique. FEBS
Lett., 1976, 66, 303-306.
Hitoshi, D., Sibata, M., Shibata, E., Morimoto, J., Akao, Y., Iinuma, M., Tanigawa, N.
and Otsuki, Y., Panaxanthone isolated from pericarp of Garcinia mangostana L.
References
129
suppresses tumor growth and metastasis of a mouse model of mammary cancer.
Anticancer Res., 2009, 29, 2485-2496.
Howard, S.S., Arachidonic Acid Pathways in Nociception. J. Support. Oncol., 2006, 4,
277-287.
Israf, D.A., Khaizurin, T.A., Syahida, A., Lajis, N.H. and Khozirah, S., Cardamonin
inhibits COX and iNOS expression via inhibition of p65NF-κB nuclear
translocation and Iκ-B phosphorylation in RAW 264.7 macrophage cells. Mol.
Immunol., 2007, 44(5), 673-679.
Israf, D.A., Tham, C.L., Syahida, A., Lajis, N.H., Sulaiman, M.R., Mohamad, A.S. and
Zakaria, Z.A. Atrovirinone inhibits proinflammatory mediator synthesis through
disruption of NF-kB nuclear translocation and MAPK phosphorylation in the
murine monocytic macrophage RAW264.7. Phytomed., 2010,17, 732-739.
Janssens, S.P., Shimouchi, A., Quertermous, T., Bloch, D.B. and Bloch, K.D., Cloning
and expression of a cDNA encoding human endothelium-derived relaxing
factor/nitric oxide synthase. J. Biol. Chem., 1992, 267, 14519-14522.
Jean, B.M., Sylvie, R., Ken, O., Jean, C.S., David, K., Olivier, R. and Jean, P.S.,
Cyclooxygenase-2 as a target for anticancer drug development. Critical Rev.
Oncol. Hematol., 2006, 59, 51-64.
Jiang, T., Peng, Z., Guoyu, L., Hang, Y., Xuexian, B., Zhongjun, M., Ning, W., Guomin,
W. and William, J., Cytotoxicity of Chinese motherwort (YiMuCao) aqueous
ethanol extract is non-apoptotic and estrogen receptor independent on human
breast cancer cells. J. Ethnopharmacol., 2009, 22, 234-239.
Ji, C. and Marnett, L.J., Oxygen radical-dependent epoxydation of (7S,8S)-
dihydroxy-7,8-dihydrobenzo[a]pyrene in mouse skin in vivo. Stimulation by
References
130
phorbol esters and inhibition by antiinflammatory steroids. J. Biol. Chem.,
1992, 267, 17842-78.
Joanna, M.K., Ken, I.O., Naomi, W., Sigridur, A.A., Jan, A.A.M.K., Robbert, J.K. and
Grietje, M., Molecular Pathways of Endothelial Cell Activation for (Targeted)
Pharmacological Intervention of Chronic Inflammatory Diseases. Curr. Vas.
Pharmacol., 2005, 3, 11-39.
Joe, D., Zheng, O., Jeffery, T., Andrew, B., Yaron, T. and Jie, L., CASTp: computed atlas
of surface topography of proteins with structural and topographical mapping of
functionally annotated residues. Nucl. Acids Res., 2006, 34, W116-W118.
Jones, G., Willett, P., Glen, R.C., Leach, A.R. and Taylor, R., Development and
validation of a genetic algorithm for flexible docking. J. Mol. Biol., 1997, 267,
727-748.
Jong, H.W., Ho-Taek, I., Yang-Hee, K., Kyung-Jin, Y., Hee-Juhn, P., Jong-Won, C. and
Kyung-Tae, L., Anti-inflammatory effect of buddlejasaponin IV through the
inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via the
NF-κB inactivation. Br. J. Pharmacol., 2006, 148, 216-225.
Jose, P.C., Noemi, C.R., Marisol, O.I. and Jazmin, M.P.R., Medicinal properties of
mangosteen (Garcinia mangostana). Food Chem. Toxicol., 2008, 46, 3227-3239.
Jung, H.A., Su, B.N., Keller, W.J., Mehta, R.G. and Kinghorn, A.D., Antioxidant
xanthones from the pericarp of Garcinia mangostana (Mangosteen). J. Agri.
Food Chem., 2006, 6, 2077-2082.
Kerwin, J.F., Lancaster, J.R. and Feldman, P.L., Nitric oxide: a new paradigm for second
messengers. J. Med. Chem., 1995, 38(22), 4343-4362.
References
131
Kleiman, A. and Tuckermann, J.P., Glucocorticoids receptor action in beneficial and side
effects of steroid therapy: lessons from conditional knockout mice. Mol. Cell.
Endocrinol., 2007, 275, 98-108.
Knowles, R.G. and Moncada, S., Nitric oxide synthases in mammals. Biochem. J., 1994,
298, 249-258.
Kulmacz, R.J. and Wang, L.H., Comparison of hydroperoxide initiator requirements for
the cyclooxygenase activities of prostaglandin H synthase-1 and -2. J. Biol.
Chem., 1995, 270, 24019-24023.
Kurumbail, R.G., Stevens, A.M., Gierse, J.K., McDonald, J.J., Stegeman, R.A., Pak, J.Y.,
Gildehaus, D., Miyashiro, J.M., Penning, T.D., Seibert, K., Isakson, P.C. and
Stallings, W.C., Structural basis for selective inhibition of cyclooxygenase-2 by
anti-inflammatory agents. Nature., 1996, 384, 644-648.
Lazarus, M., Kubata, B.K., Eguchi, N., Fujitani, Y., Urade, Y. and Hayaishi, O.,
Biochemical characterization of mouse microsomal prostaglandin E synthase-1
and its colocalization with cyclooxygenase-2 in peritoneal macrophages. Arc.
Biochem. Biophys., 2002, 397, 336-341.
Lewis, J.S., Meeke, K., Osipo, C., Ross, E.A., Kidawi, N., Li, T., Bell, E., Chandel, N.S.
and Jordan, V.C., Intrinsic mechanism of estradiol induced apoptosis in breast
cancer cells resistant to estrogen deprivation. J. Natl. Cancer Inst., 2005, 97,
1746-1759.
Liang, Y.C., Huang, Y.T., Tsai, S.H., Lin-Shiau, S.Y., Chen, C.F. and Lin, J.K.,
Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by
apigenin and related flavonoids in mouse macrophages. Carcinogenesis., 1999,
20, 1945-1952.
References
132
Lin, W.W. and Karin, M., A cytokine-mediated link between innate immunity,
inflammation, and cancer. J. Clin. Inv., 2007, 117, 1175-83.
Lindsey, D.N.D.C.N., The amazing truth about Mangosteen’s Xanthones. The
Doctors’ Prescription for Healthy Living., 2006, 10-12.
Linnaeus, C., Species Plantarum, Laurentius Salvius Publishing, 1753, 1st edn.
Lirk, P., Hoffmann, G. and Rieder, J., Inducible nitric oxide synthase-time for
reappraisal. Curr. Drug Targets Inflam. Allergy., 2002, 1(1), 89-108.
Liu, C.H., Chang, S.H., Narko, K., Ovidiu, C.T., Ming, T.W., Elizabeth, S., Christian, H.,
Timothy, F.L. and Timothy, H., Over expression of cyclooxygenase-2 is sufficient
to induce tumorigenesis in transgenic mice. J. Biol. Chem., 2001, 276, 18563-
18569.
Loibl, S., Buck, A., Strank, C., Von, M.G., Roller, M., Sinn, H.P., Schini, K.V., Solbach,
C., Strebhardt, K. and Kaufmann, M.. The role of early expression of inducible
nitric oxide synthase in human breast cancer. Eur. J. Cancer., 2005, 41, 265-71.
Lorette, C.J., Immunocytochemistry Methods and Protocols, Human Publishing, 1999,
2nd
edn.
Louise, R.H., Cyclooxygenase/prostaglandin signaling and breast cancer. Breast Cancer
Res., 2007, 9, 210.
Lowenstein, C.J., Alley, E.W., Raval, P., Snowman, A.M., Snyder, S.H., Russell, S.W.
and Murphy, W.J., Macrophage nitric oxide synthase gene: two upstream regions
mediate induction by interferon gamma and lipopolysaccharide. Proc. Nat. Aca.
Sci. USA., 1993, 90, 9730-9734.
References
133
Lowry, O.H., Rosenbrough, N.J., Farr, A.L. and Randall, R.J., Protein measurement with
the Folin phenol reagent, J. Biol. Chem., 1951, 193, 265-275.
Lucey, D.R., Clerici, M. and Shearer, G.M., Type 1 and type 2 cytokine dysregulation in
human, infectious, neoplastic and inflammatory diseases. Clin. Microbiol. Rev.,
1996, 9: 532-562.
Luisa, M., Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases.
J. Neuropathol. Exp. Neurol., 2004, 63(9), 901-10.
Luis, V., Angel, M.P., Mercedes, C., Alfonso, B., Sonia, A., Nuria, P.M., Marta, S., Rosa,
A., Juan-Carlos, S., Jordi, F. and Jose-Manuel, S., Heritability of Thromboxane
A2 and Prostaglandin E2 Biosynthetic Machinery in a Spanish Population.
Arterioscler. Thromb. Vasc. Biol., 2010, 30, 128-134.
Mahabusarakam, W., Wiriyachtra, P. and Taylor, W., Chemical constituents of Garcinia
mangostana. J. Nat. Prod., 1987, 50, 474-478.
Mahabusarakam, W., Kuaha, K., Wilairat, P. and Taylor, W.C., Prenilated xanthones as
potential antiplasmodial substances. Planta Med., 2006, 72, 912-916.
Mahesh, S.P., Patil, M.B., Ravi K. and Patil, S.R., Evaluation of anti-inflammatory
activity of ethanolic extract of Borassus flabellifer L. male flowers
(inflorescences) in experimental animals. J. Med. Plants. Res., 2009, 3, 49-54.
Mann, J.R. and Dubois, R.N., Cyclooxygenase-2 and gastrointestinal cancer. Cancer J.
2004, 10, 145-152.
Mantovani, A., Cancer: inflammation by remote control. Nature., 2005, 435 (7043), 752-
753.
References
134
Marialuigia, F., Cristina, M., Fabio, L., Antonia, P., Simona, M., Mirko, P., Lorenza, S.,
Alessandra, A., Barbara, D.F., Letizia, G., Nazzareno. and Rosa, A., Selective
Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)
acetamidine. Chem. Med. Chem., 2011, 6, 1203-1206.
Marsden, P.A., Schappert, K.T., Chen, H.S., Flowers, M., Sundell, C.L., Wilcox, J.N.,
Lamas, S. and Michel, T., Molecular cloning and characterization of human
endothelial nitric oxide synthase. FEBS Lett., 1992, 307, 287-293.
Martin, F.W., Durian and mangosteen; in Nagy S., Shaw, P.E., Tropical and Subtropical
Fruits, AVI Publishing, 1980.
Masako, N., Vijay, G., Emmanuelle, J., Meuillet, D. and Rosenberg, W., mPGES-1 as a
target for cancer suppression, A comprehensive invited review, Phospholipase A2
and lipid mediators. Biochime., 2010, 92, 660-664.
Masferrer, J.L., Zweifel, B.S., Manning, P.T., Hauser, S.D., Leahy, K.M., Smith, W.G.,
Isakson, P.C. and Seibert, K., Selective inhibition of inducible cyclooxygenase-2
in vivo is antiinflammatory and nonulcerogenic. Proc. Nat. Aca. Sci. USA.,
1994, 91, 3228-3232.
Maslinska, D. and Gajewski, M., Some aspects of the inflammatory process. Folia
Neuropathol., 1998, 36, 199-204.
Mates, J.M., Perez G.C. and Castro, I.N., Antioxidant enzymes and human diseases. Clin.
Chem., 1998, 32, 595-603.
Matsumoto, K., Akao, Y., Kobayashi, E., Ohguchi, K., Ito, T., Tanaka, T., Iinuma, M.
and Nozawa, Y., Induction of apoptosis by Xanthones from Mangosteen in
Human Leuemia cell lines. J. Nat. Prod., 2003, 66, 1124-1127.
References
135
Matsumoto, K., Akao, Y., Yi, H., Ohguchi, K., Ito, T., Tanaka, T., Kobayashi, E.,
Iinuma, M. and Nozawa, Y., Preferential target is mitochondria in α-mangostin
induced apoptosis in human leukemia HL60 cells. Bioorg. Med. Chem., 2004, 12,
5799-5806.
Matsumoto, K., Akao, Y., Ohguchi, K., Ito, T., Tanaka, T., Iinuma, M. and Nozawa, Y.,
Xanthones induce cell-cycle arrest and apoptosis in human colon cancer DLD-1
cells. Bioorg. Med. Chem., 2005, 13, 6064-6069.
Mendelson, R. and Balick, M.J., The value of undiscovered pharmaceuticals in tropical
forests. Eco. Bot., 1995, 49, 223-228.
Mercury software, http://www.ccdc.cam.ac.uk/products/mercury/
Mitchell, R.N. and Cotran, R.S., In; Robinsons Basic Pathology, Harcourt Publishing,
2000, 7th
edn.
Moncada, S., Palmer, R.M. and Higgs, E.A., Nitric oxide: physiology, pathophysiology,
and pharmacology. Pharmacol. Rev., 1991, 43, 109-142.
Morham, S., Langenbach, R., Loftin, C.D., Tiano, H.F., Vouloumanos, N., Jennette, J.
C., Mahler, J.F., Kluckman, K.D., Ledford, A., Lee, C.A. and Smothies, O.,
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the
mouse. Cell., 1995, 83, 473-482.
Morton, J., Mangosteen (Garcinia mangostana L.). In: Fruits of Warm Climates,
Creative Resources Systems Publishing, 1987.
Morris, G.M., Goodsell, D.S., Halliday, R.S., Huey, R., Hart, W.E., Belew, R.K. and
Olson, A.J., Automated Docking Using a Lamarckian Genetic Algorithm and
Empirical Binding Free Energy Function. J. Comp. Chem., 1998, 19, 1639-
1662.
References
136
Murakami, M., Uber die Konstitution des Mangostins. Liebigs. Ann., 1932, 496, 122-151.
Murakami, M., Naraba, H., Tanioka, T., Semmyo, N., Nakatani, Y., Kojima, F., Ikeda ,
T., Fueki, M., Ueno, A., Oh, S. and Kudo, I., Regulation of prostaglandin E2
biosynthesis by inducible membrane-associated prostaglandin E2 synthase that
acts in concert with cyclooxygenase-2. J. Biol. Chem., 2000, 275, 32783-32792.
Nakagawa, Y., Iinuma, M., Naoe, T., Nozawa, Y. and Akao, Y., Characterized
mechanism of α-mangostin-induced cell death: caspase-independent apoptosis
with release of endonuclease-G from mitochondria and increased miR-143
expression in human colorectal cancer DLD-1 cells. Bioorg. Med. Chem., 2007,
15, 5620-5628.
Nakane, M., Schmidt, H. H., Pollock, J. S., Forstermann, U. and Murad, F., Cloned
human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS
Lett., 1993, 316, 175-180.
Nakasone, H.Y. and Paull, R. E., Tropical Fruits, Oxford University Press Publishing,
1998.
Nakatani, K., Nakahata, N., Arakawa, T., Yasuda, H. and Ohizumi, Y., Inhibition of
cyclooxgenase and prostaglandia E2 synthesis by cmangostin, a xanthone
derivative in mangosteen, in C6 rat glioma cells. Biochem. Pharmacol., 2002, 63,
73-79.
Nakatani, K., Yamakuni, T., Kondo, N., Arakawa, T., Oosawa, K., Shimura, S., Inoue, H.
and Ohizumi, Y., γ-Mangostin inhibits inhibitor-κB kinase activity and decreases
lipoplysaccharide-induced cyclooxygenase-2 gene expression in C6 rat glioma
cells. Mol. Pharmacol., 2004, 66, 667-674.
References
137
Nandini, V., Subhash, K., Tripathi, D.S., Hasi, R.D. and Rakha, H.D., Evaluation of
inhibitory activities of plant extracts on production of LPS-stimulated pro-
inflammatory mediators in J774 murine macrophages. Mol. Cell. Biochem., 2009,
36, 127-135.
Nathan, C., Nitric oxide as a secretory product of mammalian cells. FASEB J., 1992, 6,
3051-3064.
Nathan, C., Points of control in inflammation. Nature., 2002, 420, 846-852.
Nelson, G., De Marzo, M., DeWeese, T.L., and Isaacs, B., The role of inflammation in
the pathogenesis of prostate cancer. J. Urol., 2004, 172, S6-S11.
Nguyen, K.D. and Lee, D.A., Effects of steroids and nonsteroidal anti-inflammatory
agents on human ocular fibroblast. Inv. Ophthalmol. Visual Sci., 1992, 33, 2693-
2701.
Newman, D.J, Cragg, G.M. and Snader, K.M., The influence of natural products upon
drug discovery. Nat. Prod. Rep., 2000, 17, 215-234.
O’Byrne, J. and Dalgleish, G., Chronic immune activation and inflammation as the cause
of malignancy. Br. J. Cancer., 2001, 85, 473-483.
Ok-Kyoung, K., Mee-Young, L., Ji-Eun, Y., Sei-Ryang, O., Young-Won, C., Hyeong-
Kyu, L. and Kyung-Seop, A., Anti-inflammatory effects of methanol extracts of
the root of Lilium lancifolium on LPS-stimulated Raw 264.7 cells. J.
Ethnopharmacol., 2010, 130, 28-34.
Pahl, H.L., Activators and target genes of Rel/NF-κB transcription factors. Oncogene.,
1999,18(49), 6853-6866.
References
138
Panchawat, S. and Sisodia, S.S., In vitro antioxidant activity of Saraca asoca Roxb. De
Wilde stem bark extracts from various extraction processes. Asi. J. Pharm. Clin.
Res., 2010, 3(3), 231-233.
Park, K.I., Sang-Rim, K., Hyeon-Soo, Park., Do, H.L., Arulkumar, N.,
Jin, A.K.,
Sung,
C.S., Eun, H.K.,
Won, S. L.,
Hyon-Jong, C.,
Su, J.An.
and Gon, S.K., Regulation
of Proinflammatory Mediators via NF-κB and p38 MAPK-Dependent
Mechanisms in RAW 264.7 Macrophages by Polyphenol Components Isolated
from Korea Lonicera japonica THUNB. Evid. Based Complement. Alternat.
Med., 2012, 2012, 1-10.
Pereira, J.V., Modesto, F.J., Agra, M.F. and Barbosa, F.J.M., Plant and Plant derived
compounds employed in prevention of the osteoporosis. Acta Farmaceutica
Bonaerense., 2002, 21, 223-234.
Piccagli, L., Fabbri, E., Monica, B., Valentino, B., Irene, M., Elena, N., Maria, C.D.,
Ilaria, L., Giulio, C. and Roberto, G., Docking of molecules identified in bioactive
medicinal plants extracts into the p50 NF-kappaB transcription factor: correlation
with inhibition of NF-kappaB/DNA interactions and inhibitory effects on IL-8
gene expression. BMC Struc. Biol., 2008, 8, 38.
PK/DB, http://www.miro.ifsc.usp.br/pkdb/
Pothitirat, W. and Gritsanapan, W., HPLC quantitative analysis method for the
determination of α-mangostin in mangosteen fruit rind extract. Thai J. Agr. Sci.,
2009, 42, 7-12.
Prashanth, K.V., Shashidhara, S., Kumar, M.M. and Sridhara, B.Y., Effect of Luffa
echinta on lipid peroxidation and free radical scavenging activity. J. Pharm.
Pharmacol., 2000, 52, 891.
References
139
Primchanien, M., Nuttavut, K., Sineenart, K., Omboon, L., Narongchai, P. and Neelobol,
N., Antiproliferation, antioxidation and induction of apoptosis by Garcinia
mangostana (mangosteen) on SKBR3 human breast cancer cell line. J.
Ethnopharmacol., 2004, 90, 161-166.
Protein Data Bank, http://www.rcsb.org/pdb/
PyMOL molecular visualization tool, http://www.pymol.org/
Raghav, S.K., Gupta, B., Shrivastava, A. and Das, H.R., Inhibition of lipopolysaccharide-
inducible nitric oxide synthase and IL-1β through suppression of NF-κB
activation by 3-(1’-1’-dimethyl-allyl)- 6-hydroxy-7-methoxy-coumarin isolated
from Ruta graveolens L. Eur. J. Pharmacol., 2007, 560,69-80.
Raskin, I., Ribnicky, D.M., Komarnytsky, S., Nebojsa, I., Alexander, P., Nikolai, B.,
Anita, B., Diego, A.M., Christophe, R., Nir, Y., Joseph, M.O.N., Teresa, C., Ira,
P. and Bertold, F., Plants and human health in the 21st century. Trends
Biotechnol., 2002, 20, 522-531.
Raskin, I. and Ripoll, C., Can an apple a day keep the doctor away?. Curr. Pharm. Des.,
2004, 10, 3419-3429.
Reddy, R.N., Mutyala, R., Aparoy, P., Reddanna, P. and Reddy, M.R., Computer aided
drug design approaches to develop cyclooxygenase based novel anti-
inflammatory and anti-cancer drugs. Curr. Pharm. Des., 2007, 13(34), 3505-17.
Riddell, R.J., Clothier, R. H. and Balls, M., An evaluation of three in vitro cytotoxicity
assays. Food Chem. Tox., 1986, 24, 469-471.
Roberts, P.J., Riley, G.P., Morgan, K., Miller, R., Hunter, J.O. and Middleton, S.J., The
physiological expression of inducible nitric oxide synthase (iNOS) in the human
colon. J. Clin. Pathol., 2001, 54(4), 293-297.
References
140
Rocca, B., Targeting PGE2 receptor subtypes rather than cyclooxygenases: a bridge over
troubled water?. Mol. Interv. 2006, 6, 68-73.
Saeed, M., Khan, H., Khan, M.A., Simjee, S.U., Muhammad, N. and Khan, S.A.,
Phytotoxic, insecticidal and leishmanicidal activities of aerial parts of
Polygonatum verticillatum. Afr. J. Biotechnol., 2010, 9, 1241-1244.
Sahara, S., Aoto, M., Eguchi, Y., Imamoto, N., Yoneda, Y. and Tsujimoto, Y., Acinus is
a caspase-3-activated protein required for apoptotic chromatin condensation.
Nature., 1999, 401, 168-173.
Sainani, G.S., Manika, J.S. and Sainani, R.G., Oxidative stress: a key factor in
pathogenesis of chronic diseases. Med. uptake., 1997, 1, 1-4.
Sakagami, Y., Iinuma, M., Piyasena, K.G.N.P., Dharmaratne, H.R.W., Antibacterial
activity of α-mangostin against vancomycin resistant Enterococci (VRE) and
synergism with antibiotics. Phytomed., 2005, 12, 203-208.
Sakahira, H., Enari, M. and Nagata, S., Cleavage of CAD inhibitor in CAD activation and
DNA degradation during apoptosis. Nature., 1998, 391, 96-99.
Salvemini, D., Ischiropoulos, H. and Cuzzocrea, S., Roles of nitric oxide and superoxide
in inflammation. Methods Mol. Biol., 2003, 225, 291-303.
Sambrook, J., Fritsch, E.F. and Maniatis, T., Molecular Cloning: A Laboratory Manual,
Cold Spring Harbor Publishing, 1989, 1st edn.
Samuelsson, B., Dahlen, S.E., Lindgren, J.A., Rouzer, C.A. and Serhan, C.N.,
Leukotrienes and lipoxins: structures, biosynthesis, and biological effects.
Science., 1987, 237, 1171-6.
References
141
Sandrea, M.F., Amit, M., Manishika, S. and Prasad, V.B., Design of Benzene -1,2
diamines as selective inducible nitric oxide synthase inhibitors: a combined de
novo design and docking analysis. J. Mol .Mod., 2008, 14(3), 215-224.
Sang, R.K., Dae, Y.H., Kwang, I.P., Hyeon, S.P., Yong, B.C., Hu J.L., Won, S.L.,
Chung, H.R., Yeong, L.H., Do, H.L., Jin, A.K. and Gon, S.K., Suppressive Effect
on Lipopolysaccharide-Induced Proinflammatory Mediators by Citrus aurantium
L. in Macrophage RAW264.7 Cells via NF-κB Signal Pathway. Evid. Based
Complement. Alternat. Med., 2011, 2011, 1-12.
Schmid, W., Ueber das mangostin. Liebigs. Ann. Chem., 1855, 93, 83-89.
Serhan, C.N., Yang, R., Martinod, K., Kasuga, K., Pillai, P.S., Porter, T.F., Oh, S.F.
and Spite, M., Maresins: novel macrophage mediators with potent
antiinflammatory and proresolving actions. J. Exp. Med., 2009, 206(1), 15-23.
Seril, D.N., Liao, J., Yang, G.Y. and Yang, C.S., Oxidative stress and ulcerative colitis-
associated carcinogenesis: studied in humans and animal models.
Carcinogenesis., 2003, 24, 353-362.
Shacter, E. and Weitzman, S.A., Chronic inflammation and cancer. Oncol., 2002, 16,
217-226.
Sharma, J.N., Al-Omran, A. and Parvathy, S.S., Role of nitric oxide in inflammatory
diseases, Inflammopharmacol., 2007, 15 (6), 252-259.
Sharma. U.S., Sharma, U.K., Sutar, N., Singh, A. and Shukla, D.K., Anti-inflammatory
activity of Cordia dichotoma forst f. seeds extracts. Int. J. Pharm. Ana., 2010,
2(1), 1-4.
References
142
Sherman, P.A., Laubach, V.E., Reep, B.R. and Wood, E.R., Purification and cDNA
sequence of an inducible nitric oxide synthase from a human tumor cell line.
Biochem., 1993, 32, 11600-11605.
Shivaji, B.B., Nargund, L.V.G., Sachindra, L.N., Devaraju, K.S. and Shruthi, S.D.
Synthesis, In-vivo and In-silico anti-inflammatory studies of substituted fluoro
pyrazole. Res. J. Pharm. Biol. Chem. Sci., 2011, 2(3), 119-127.
Simon, L.S., Weaver, A.L., Graham, D.Y., Kivitz, A.J., Lipsky, P.E., Hubbard, R.C.,
Isakson, P.C., Verburg, K.M., Yu, S.S., Zhao, W.W. and Geis, G.S., Anti-
inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid
arthritis: a randomized controlled trial. JAMA., 1999, 282, 1921-8.
Simmons, D.L., Botting, R.M. and Hla, T., Cyclooxygenase isozymes: the biology of
prostaglandin synthesis and inhibition. Pharm. Rev., 2004, 56, 387-437.
Simonian, N.A. and Coyle, J.Y., Oxidative stress in neurodegenerative diseases, Ann.
Rev. Pharmacol. Toxicol., 1996, 36, 83-106.
Singh, N.P., McCoy, M.T., Tice, R.R. and Schneider, E.L., A simple technique for
quantitation of low DNA levels of DNA damage in individual cells. Exp. Cell
Res., 1988, 175, 184-191.
Singh, R., Kumar, R. and Singh, D.P., Nitric oxide-releasing nonsteroidal anti-
inflammatory drugs: gastrointestinal-sparing potential drugs. J. Med. Food.,
2009, 12(1), 208-218.
Smith, W.L., Garavito, R.M. and Dewitt, D.L., Prostaglandin endoperoxide H synthases
cyclooxygenase-1 and -2. J. Biol. Chem., 1996, 271, 33157-33160.
References
143
Soslow, R.A., Dannenberg, A.J., Rush, D., Woerner, B.M., Khan, K.N., Masferrer, J.
and Koki, A.T., COX-2 is expressed in human pulmonary, colonic, and mammary
tumors. Cancer., 2000, 89, 2637-2645.
Souhila, B.T., Amel, T.M., Boubekeur, M., Safia. and Tairi.K., Modeling the binding
modes of stilbene analogs to cyclooxygenase-2: a molecular docking study. J.
Mol. Model., 2010, 16, 1919-1929.
Sreejayan, N. and Rao, M.N.A., Nitric oxide scavenging by curcuminoids. J. Pharm.
Pharmacol., 1997, 49, 105-107.
Stables, M.J. and Gilroy, D.W., Old and new generation lipid mediators in acute
inflammation and resolution. Prog. Lipid. Res., 2011, 50, 35-51.
Stark, K., Bylund, J., Torma, H., Sahlen, G. and Oliw E.H., On the mechanism of
biosynthesis of 19-hydroxyprostaglandins of human seminal fluid and
expression of cyclooxygenase-2, PGH 19-hydroxylase (CYP4F8) and
microsomal PGE synthase-1 in seminal vesicles and vas deferens. Prost. Lipid
Mediat., 2005, 75, 47-64.
Stratton, M.S. and Alberts, D.S., Current application of selective COX-2 inhibitors in
cancer prevention and treatment. Oncol., 2002, 16, 37-51.
Strober, W., Trypan Blue Exclusion Test of Cell Viability. Curr. Prot. Immunol., 2001,
21, A.3B.1-A.3B.2.
Stuehr, D.J., Kwon, N.S., Nathan, C.F., Griffith, O.W., Feldman, P.L. and Wiseman,
J.N., Omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric
oxide from L- arginine. J. Biol. Chem., 1991, 266(10), 6259-6263.
References
144
Subbaramaiah, K. and Dannenberg, A.J., Cyclooxygenase 2: a molecular target for
cancer prevention and treatment. Trends Pharmacol. Sci., 2003, 24, 96-102.
Suksamrarn, S., Suwannapoch, N., Ratananukul, P., Aroonlerk, N. and Suksamrarn, A.,
Xanthones from the green fruit hulls of Garcinia mangostana. J. Nat. Prod.,
2002, 5, 761-763.
Suksamrarn, S., Komutiban, O., Ratananukul, P., Chimnoi, N., Lartpornmatulee, N. and
Suksamrarn, A., Cytotoxic prenylated xanthones from the young fruit of Garcinia
mangostana. Chem. Pharm. Bull., 2006, 3, 301-305.
Surh, Y.J., Chun, K.S., Cha, H.H., Han, S.S., Keum, Y.S., Park, K.K. and Lee, S.S.,
Molecular mechanisms underlying chemopreventive activities of anti-
inflammatory phytochemicals: down-regulation of COX-2 and iNOS through
suppression of NF-kappa B activation. Mutat. Res., 2001, 243-68.
Swiss-PdbViewer, http://www.ca.expasy.org/spdbv/
Tanabe, T. and Tohnai, N., Cyclooxygenase isozymes and their gene structures and
expression. Prost. Lipid Mediat., 2002, 95-114.
Teri, L., Marchele, N., Shailesh, S. and Gary, L.S., Inhibition of cyclooxygenase-2
decreases breast cancer cell motility, invasion and matrix metalloproteinase
expression. BMC Can., 2006, 81, 1471-2407.
Tewtrakul, S., Wattanapiromsakul, C. and Mahabusarakam, W., Effects of compounds
from Garcinia mangostana on inflammatory mediators in RAW264.7
macrophage cells. J. Ethnopharmacol., 2009, 121, 379-382.
References
145
Thiemermann, C., Wu, C.C., Szabo, C., Perretti, M. and Vane, J.R., Role of tumour
necrosis factor in the induction of nitric oxide synthase in a rat model of
endotoxin shock. Br. J. Pharmacol., 1993, 110(1), 177-182.
Thomsen, L.L, Miles, D.W., Happerfield, L., Bobrow, L.G., Knowles, R.G. and
Moncada, S., Nitric oxide synthase activity in human breast cancer. Br. J.
Cancer., 1995, 72, 41-4.
Thornberry, N.A. and Lazebnik, Y., Caspases: enemies within. Science., 1998, 281,
1312-1316.
Tiago, L.M., Montanari, C.A. and Andricopulo, A.D., Hologram QSAR model for the
prediction of human oral bioavailability. Bioorg. Med. Chem., 2007, 15, 7738-
7745.
Tiago, L.M., Leonardo, G.T., Alexandre, E.C. and Adriano, D.A., PK/DB: database for
pharmacokinetic properties and predictive in silico ADME models.
Bioinformatics., 2008, 24(19), 2270-2271.
Tsujii, M. and Bois Du, R.N., Alterations in cellular adhesion and apoptosis in epithelial
cells overexpressing prostaglandin endoperoxide synthase 2. Cell., 1995, 83, 493-
501.
Umamaheshwari, D.P., Ujjawal, G., Parisa , K., Hema, V., Ryan, J.A., Vivek, N., Anand,
R. and Sandeep, P., Gambogic acid covalently modifies IkB kinase-β subunit to
mediate suppression of lipopolysaccharide-induced activation of NF-κB in
macrophages. Biochem. J., 2009, 419 (2), 401-9.
Upreti, M., Sanjiv, K. and Pramod, C.R., Replacement of 198
MQMDII203
of mouse IRF-1
by 197
IPVEVV202
of human IRF-1 abrogates induction of IFN-β, iNOS, and COX-
2Mgene expression by IRF-1. Biochem. Biophy. Res. Comm., 2004, 314, 737-744.
References
146
Van, D.D.W.A., Tsai, A.L. and Kulmacz, R.J., The cyclooxygenase reaction
mechanism. Biochem., 2002, 41, 15451-15458.
Vane, J.R., Mitchell, J.A., Appleton, I., Tomlinson, A., Bishop-Bailey, D., Croxtall, J.
and Willoughby, D.A., Inducible isoforms of cyclooxygenase and nitric oxide
synthase in inflammation. Proc. Nat. Acad. Sci. USA., 1994, 91, 2046-2050.
Vane, J.R. and Botting, R.M., Mechanism of action of anti-inflammatory drugs. Int.
J. Tissue Res., 1998, 20, 3-15.
Vendemiate, G., Grattaglianol, I. and Altomare, E., An update on the role of free radicals
and antioxidants defense in human disease. Int. J. Clin. Lab. Res., 1999, 29, 49-
55.
Vermont, P.D., Mark, A.B. and Elvira, G.D.M.B.B., Inhibitor and Genistein among Soy
Compounds That Synergistically Inhibit Nitric Oxide and Prostaglandin E2
Pathways in Lipopolysaccharide-Induced Macrophages. J. Agr. Food Chem.,
2008, 56, 11707-11717.
Vishnu, P.V., Mallika, J., Surapaneni, K.M., Karthik, B., Saraswathi, P. and Chandra,
S.G., Toxicity study of Garcinia mangostana Linn., Pericarp extract in rats,
Asi. J. Exp. Biol. Sci., 2010, 1(3), 633-637.
Von, K.A., Callsen, D. and Brune, B., Superoxide attenuates macrophage apoptosis
by NF kappa B and AP-1 activation that promotes cyclooxygenase-2 expression.
J. Immunol., 1999, 163, 2858-2866.
Wang, C.C., Lai, J.E., Chen, L.G., Yen, K.Y. and Yang, L.L., Inducible nitric oxide
synthase inhibitor of Chinese herbs part II: naturally occurring furanocoumarins.
Bioorg. Med. Chem., 2000, 8, 2701-2707.
References
147
Wang, D. and Raymon, N.D., Cyclooxygenase-2: a potential target in breast
cancer. Semin. Oncol., 2004, 31(3), 64-73.
Weecharangsan ,W., Opanasopit, P., Sukma, M., Ngawhirunpat, T., Sotanaphun, U. and
Siripong, P., Antioxidative and neuroprotective activities of extracts from the fruit
hull of mangosteen (Garcinia mangostana Linn.). Med. Prin. Prac., 2006,
15(4), 281-7.
Weiming, X.U., Li, Z.L., Marilena, L., Mohamed, A. and Ian, G.C., The role of nitric
oxide in cancer. Cell Res., 2002, 12(5-6), 311-320.
Weinberg, J.B., Nitric oxide synthase 2 and cyclooxygenase 2 interactions in
inflammation. Immunol. Res., 2000, 22, 319-341.
Wendy, K.A., Anthony, D.R.A., Caroline, C., John, D.,
Edward, G., Salvador, M.,
Jayne,
M., Daryl, R., Linda, J.R., Rachel, J.R.,
Sheila, S., Neil, W. and Richard, G.K.,
GW274150 and GW273629 are potent and highly selective inhibitors of inducible
nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol., 2005, 145(3), 301-
312.
Whitcomb, C., Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer.
Am. J. Physiol., 2004, 287, G315-G319.
Williams, P., Ongsakul, M., Proudfoot, J., Croft, K. and Beilin, L., Mangostin inhibits
the oxidative modification of human low density lipoprotein. Free Radic. Res.,
1995, 23, 175-184.
Winston, B.W., Krein, P., Shehzad, I., Yong, H. and Connie, M., TNFα-regulated
insulin-like growth factor-I (IGF-I) promoter activity in macrophages. Am. J.
Res. Crit. Care Med., 1999, 159(3), A442.
References
148
Winter, C.A., Risky, E. A. and Nuss, G.W., Carrageenan induced oedema in hind paw of
the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med., 1962,
11I, 544-547.
World Health Organization. The World Health Organization report, 2002.
Xiaofeng, L., Robert, N.A. and Bruce, S.K., Preparation and evaluation of new L-
canavanine derivatives as nitric oxide synthase inhibitors. Tetrahedron., 2001, 57,
6557-6565.
Yates, P. and Stout, G.H., The structure of mangostin. J. Am. Chem. Soc., 1958, 80,
1691-1700.
Yona, S. and Gordon, S., Inflammation: Glucocorticoids turn the monocyte switch.
Immunol. Cell Biol., 2007, 85, 81-82.
Yun, H.Y., Dawson, T.T. and Dawson, T.M., Neurobiology of nitric oxide. Crit. Rev.
Neurobiol., 1996, 10, 291-316.
Yunjie, S., Xi, M.T., Elizabeth, H., Tien, K.M. and Frank. A.S., Cyclooxygenase-2
Overexpression Reduces Apoptotic Susceptibility by Inhibiting the Cytochrome
c-dependent Apoptotic Pathway in Human Colon Cancer Cells. Cancer Res.,
2002, 62, 6323-6328.
Zhang, V., O’Sullivan, M., Hussain, H., Roswit, W.T. and Holtzman, M.J., Molecular
cloning, functional expression, and selective regulation of ovine prostaglandin H
synthase-2. Biochem. Biophys. Res. Commun., 1996, 227, 499-506.